211 related articles for article (PubMed ID: 38420949)
1. Nanomaterials-Involved Tumor-Associated Macrophages' Reprogramming for Antitumor Therapy.
Li SL; Hou HY; Chu X; Zhu YY; Zhang YJ; Duan MD; Liu J; Liu Y
ACS Nano; 2024 Mar; 18(11):7769-7795. PubMed ID: 38420949
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful.
Szulc-Kielbik I; Kielbik M
Exp Suppl; 2022; 113():107-140. PubMed ID: 35165862
[TBL] [Abstract][Full Text] [Related]
3. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
6. Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy.
Liang C; Zhang Y; Wang S; Jiao W; Guo J; Zhang N; Liu X
J Mater Chem B; 2024 May; 12(20):4809-4823. PubMed ID: 38695349
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
[TBL] [Abstract][Full Text] [Related]
8. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
[TBL] [Abstract][Full Text] [Related]
9. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
10. Embryonic Origin and Subclonal Evolution of Tumor-Associated Macrophages Imply Preventive Care for Cancer.
Zhang XM; Chen DG; Li SC; Zhu B; Li ZJ
Cells; 2021 Apr; 10(4):. PubMed ID: 33919979
[TBL] [Abstract][Full Text] [Related]
11. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
Zheng P; He J; Fu Y; Yang Y; Li S; Duan B; Yang Y; Hu Y; Yang Z; Wang M; Liu Q; Zheng X; Hua L; Li W; Li D; Ding Y; Yang X; Bai H; Long Q; Huang W; Ma Y
ACS Nano; 2024 Mar; 18(9):6863-6886. PubMed ID: 38386537
[TBL] [Abstract][Full Text] [Related]
12. Immunostimulation of tumor microenvironment by targeting tumor-associated macrophages with hypoxia-responsive nanocomplex for enhanced anti-tumor therapy.
Kang Y; Lim J; Saravanakumar G; Kim J; Park M; Im S; Kim WJ
J Control Release; 2022 Mar; 343():78-88. PubMed ID: 35065158
[TBL] [Abstract][Full Text] [Related]
13. Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth.
Ramesh A; Malik V; Brouillard A; Kulkarni A
J Biomed Mater Res A; 2022 Aug; 110(8):1448-1459. PubMed ID: 35388955
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs.
Shao S; Miao H; Ma W
Front Immunol; 2023; 14():1295684. PubMed ID: 38035068
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
Wang Y; Wang D; Yang L; Zhang Y
Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
[TBL] [Abstract][Full Text] [Related]
16. Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages.
Zhang Y; Chen Y; Li J; Zhu X; Liu Y; Wang X; Wang H; Yao Y; Gao Y; Chen Z
ACS Appl Mater Interfaces; 2021 Jun; 13(21):24442-24452. PubMed ID: 34008947
[TBL] [Abstract][Full Text] [Related]
17. Development of functional nanomedicines for tumor associated macrophages-focused cancer immunotherapy.
Wei X; Wang J; Liang M; Song M
Theranostics; 2022; 12(18):7821-7852. PubMed ID: 36451865
[TBL] [Abstract][Full Text] [Related]
18. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
Li L; Tian Y
Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
[TBL] [Abstract][Full Text] [Related]
19. A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages.
Ren Y; Wang M; Yuan H; Wang Z; Yu L
Int Immunopharmacol; 2024 Jun; 135():112319. PubMed ID: 38801810
[TBL] [Abstract][Full Text] [Related]
20. [A Review of the Lipid Metabolism Reprogramming in Tumor Associated Macrophages].
Zhao K; Shi RC; Miao HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 52(1):45-49. PubMed ID: 33474888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
